Victor Gueutin

ORCID: 0000-0003-1287-5480
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Renal Transplantation Outcomes and Treatments
  • Renal Diseases and Glomerulopathies
  • Parathyroid Disorders and Treatments
  • Complement system in diseases
  • Ion Transport and Channel Regulation
  • Muscle and Compartmental Disorders
  • Renal function and acid-base balance
  • Eosinophilic Disorders and Syndromes
  • Dialysis and Renal Disease Management
  • Amyloidosis: Diagnosis, Treatment, Outcomes
  • Chronic Kidney Disease and Diabetes
  • Drug-Induced Hepatotoxicity and Protection
  • Renal cell carcinoma treatment
  • Electrolyte and hormonal disorders
  • Nephrotoxicity and Medicinal Plants
  • Cancer Immunotherapy and Biomarkers
  • Vasculitis and related conditions
  • Thyroid Disorders and Treatments
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Transplantation: Methods and Outcomes
  • Multiple and Secondary Primary Cancers
  • Potassium and Related Disorders
  • Drug-Induced Adverse Reactions
  • Pharmacological Effects and Toxicity Studies
  • Metabolism and Genetic Disorders

Université de Caen Normandie
2022-2024

Centre Hospitalier Universitaire de Caen
2022-2024

Normandie Université
2024

Pitié-Salpêtrière Hospital
2011-2021

Sorbonne Université
2011-2021

Association pour l'Utilisation du Rein Artificiel
2015-2021

Assistance Publique – Hôpitaux de Paris
2012-2019

Laboratoire d'études sur les monothéismes
2014

Délégation Paris 6
2014

Centre de Recherche des Cordeliers
2013

Expanded clinical experience with patients taking antiangiogenic compounds has come increasing recognition of the renal adverse effects. Because histology is rarely sought in those patients, consequences are underestimated. Antiangiogenic-treated-cancer who had a biopsy for effects from 2006 to 2013, were included current study. Clinical features and histologic findings reviewed. Our cohort was 100 (58 women) biopsy-proven kidney disease using anti-vascular endothelial growth factor (VEGF)...

10.1097/md.0000000000000207 article EN cc-by-nc Medicine 2014-11-01

Inactivation of the B1 proton pump subunit (ATP6V1B1) in intercalated cells (ICs) leads to type I distal renal tubular acidosis (dRTA), a disease associated with salt- and potassium-losing nephropathy. Here we show that mice deficient ATP6V1B1 (Atp6v1b1-/- mice) displayed loss NaCl, K+, water, causing hypovolemia, hypokalemia, polyuria. We demonstrated NaCl originated from cortical collecting duct, where activity both epithelial sodium channel (ENaC) pendrin/Na(+)-driven chloride/bicarbonate...

10.1172/jci63492 article EN Journal of Clinical Investigation 2013-09-23

Avacopan, a selective C5aR1 inhibitor, recently emerged as glucocorticoid (GCs) sparing agent in ANCA-associated vasculitis (AAV). We aim to evaluate the tolerance and efficacy of avacopan given outside randomized clinical trials or with severe kidney involvement.

10.1093/rheumatology/keae359 article EN Lara D. Veeken 2024-07-13

Secondary hyperparathyroidism (SHPT) is frequent in haemodialysis (HD) patients. Oral cinacalcet-hydrochloride (HCl) decreases parathyroid hormone (PTH); however, real-life PTH data, according to Kidney Disease: Improving Global Outcomes (KDIGO) guidelines, are still lacking. Our goal assess the percentage of cinacalcet-HCl-treated HD patients with controlled SHPT (PTH <9× upper limit normal range) after 12 months (M12) treatment.This a retrospective observational study treated by...

10.1093/ckj/sfz021 article EN cc-by-nc Clinical Kidney Journal 2019-02-01

The hypereosinophilic syndromes (HESs) are a group of disorders marked by the sustained overproduction eosinophils, in which eosinophilic infiltration and mediator release cause damage to multiple organs. In idiopathic HES, underlying hypereosinophilia (HE) remains unknown despite thorough aetiological work-up. Kidney disease is thought be rare HES. Renal manifestations described include interstitial nephritis, various types glomerulopathies, thrombotic microangiopathy (TMA) electrolyte...

10.1093/ckj/sft046 article EN cc-by-nc Clinical Kidney Journal 2013-05-28

Malaria, a potentially life-threatening disease, is the most prevalent endemic infectious disease worldwide. In modern era, spectrum of glomerular involvement observed in patients after malarial infections remains poorly described.We therefore performed retrospective multicenter study to assess clinical, biologic, pathologic, and therapeutic characteristics with demonstrated by kidney biopsy France within 3 months an acute malaria episode.We identified 23 (12 men), all but 1 African ancestry...

10.2215/cjn.00590120 article EN Clinical Journal of the American Society of Nephrology 2020-05-22

Onconephrology is a growing discipline that aims to improve the management of patients with cancer and kidney disease. If histology an essential key, anatomopathological data remain weak although this complex management. Patients active who had biopsy (KB) between 2014 2020 were included, their clinicobiological histological analyzed retrospectively. Our cohort consisted 154 (83 women) mean age 58 years. One hundred twelve presented proteinuria, 95 acute injury, 59 arterial hypertension....

10.1186/s12882-024-03812-7 article EN cc-by-nc-nd BMC Nephrology 2024-10-19

Nonhematologic malignancies are rarely reported to be associated with AA amyloidosis. Although the association between renal cell carcinoma and systemic amyloidosis has been established, evidence linking pulmonary cancer is scarce. Here, a case of biopsy-proven complicated nephrotic syndrome lung reported.

10.1155/2013/831903 article EN cc-by Case Reports in Nephrology 2013-01-01

Gueutin V, Ficheux M, Châtelet Lecouf A, Henri P, Hurault de Ligny B, Ryckelynck J-P, Lobbedez T. Hydration status of patients with end-stage renal disease after kidney transplantation. Clin Transplant 2011: 25: E656–E663. © 2011 John Wiley & Sons A/S. Abstract: Background: This study was carried out to estimate the modification hydration within first three months Subjects and methods: Fifty who underwent a allograft were prospectively followed for transplantation assess by bioimpedance...

10.1111/j.1399-0012.2011.01496.x article EN Clinical Transplantation 2011-08-24

Background: Thrombotic microangiopathies (TMAs) can be induced by drugs. Recent works have indicated proteasome inhibitors, including carfilzomib, as a possible new causative agent. Although the physiopathology and management of carfilzomib-induced TMA are still unknown, eculizumab seems to efficient. Results: We report clinical case during carfilzomib treatment for multiple myeloma, possibly triggered concomitant influenza infection, suggesting multi-hit process. Histologic analysis kidney...

10.3390/kidneydial2040056 article EN cc-by Kidney and Dialysis 2022-12-12

The approval of febuxostat, a non-purine analogue inhibitor xanthine oxidase, by the European Medicines Agency and US Food Drug Administration, heralds new era in treatment gout [1]. most commonly reported adverse drug reactions were liver function abnormalities, diarrhoea, headache, nausea, dizziness and/or altered taste. Only one case cutaneous leukocytoclastic vasculitis has been with febuxostat [2]. In this report, we provide first anti-neutrophil cytoplasmic antibody (ANCA)-positive...

10.1093/ckj/sfs092 article EN Clinical Kidney Journal 2012-10-01

We report a case of renal thrombotic microangiopathy (TMA) in myeloproliferative variant hypereosinophilic syndrome (HES) 24-year-old man which resolved with imatinib therapy. This is one few cases the literature to date describing TMA HES, suggesting that pathogenesis thrombosis at least part related damage from activated eosinophils.

10.1093/ckj/sft067 article EN cc-by-nc Clinical Kidney Journal 2013-07-31

The anti-neutrophil cytoplasmic antibody (ANCA) renal risk score (ARRS) for predicting survival in ANCA-associated vasculitis (AAV) had not previously been validated adults over 65 years of age and presenting impairments associated with an aging kidney, a high cardiovascular comorbidity burden prevalent microscopic polyangiitis.

10.1093/ckj/sfae135 article EN cc-by-nc Clinical Kidney Journal 2024-04-29
Coming Soon ...